iPSC culture techniques for drug discovery and therapeutics

AMSBIO has released a comprehensive online article highlighting the critical role of culture techniques in the use of induced pluripotent stem cells (iPSCs) for drug discovery and therapeutic applications. iPSCs represent an invaluable tool in these fields, but their effectiveness hinges on the ability to generate homogeneous cultures.

The article emphasises the significance of maintaining genetic stability, optimising culture conditions, and effectively managing single-cell expansion to ensure reproducibility and product quality. It discusses the use of chemically defined media, such as the advanced StemFit® product, which offers precise control over the cell growth environment, ensuring consistency across experiments. This consistency is essential for developing scalable protocols for iPSC culture and differentiation, which are crucial for clinical application.

Additionally, the article covers the vital role of cryopreservation in preserving iPSCs and organoids. It highlights the importance of using chemically defined, animal origin-free cryopreservation media like STEM-CELLBANKER® to maintain high yields and ensure the long-term viability of stem cells, even after extended storage.

Looking ahead, the article explores challenges in advancing 3D iPSC cultures, such as uncontrolled spheroid aggregation and cell shear stress. It introduces a novel approach using Laminin E8 fragments to create an effective extracellular matrix (ECM), fostering efficient stem cell production.

Read the complete article.

More information online